Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Sickle Cell-thalassemia Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)WithdrawnNCT04474626
What this trial is testing

Isoquercetin in Sickle Cell Anemia

Who this might be right for
Sickle Cell DiseaseSickle Cell-Beta0-Thalassemia
Jeffrey Zwicker, MD
Not applicableUnknownNCT04090268
What this trial is testing

Precision Exercise in Children With Malignant Hemopathies

Who this might be right for
Leukemia, Myeloid, AcuteLeukemia, B-cellLeukemia, T Cell+5 more
University of Milano Bicocca 380
Testing effectiveness (Phase 2)Active Not RecruitingNCT00061568
What this trial is testing

Improving the Results of Bone Marrow Transplantation for Patients With Severe Congenital Anemias

Who this might be right for
Congenital Hemolytic AnemiaSickle Cell Disease
National Heart, Lung, and Blood Institute (NHLBI) 130
Not applicableStudy completedNCT01241357
What this trial is testing

High-Tc Susceptometer to Monitor Transfusional Iron Overload

Who this might be right for
Transfusional Iron OverloadThalassemia MajorSickle Cell Disease+2 more
Columbia University 99
Large-scale testing (Phase 3)Study completedNCT01179217
What this trial is testing

A Phase III Safety and Efficacy Study of L-Glutamine to Treat Sickle Cell Disease or Sickle βo-thalassemia

Who this might be right for
Sickle Cell AnemiaSickle ß0-Thalassemia
Emmaus Medical, Inc. 230
Testing effectiveness (Phase 2)Study completedNCT04987489
What this trial is testing

Etavopivat in Patients With Thalassemia or Sickle Cell Disease

Who this might be right for
Sickle Cell DiseaseThalassemia
Forma Therapeutics, Inc. 53
Early research (Phase 1)Study completedNCT00005783
What this trial is testing

A Phase I/II Trial of Recombinant-Methionyl Human Stem Cell Factor (SCF) in Adult Patients With Sickling Disorders

Who this might be right for
Hemoglobin SC DiseaseSickle Cell Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 50
Not applicableStudy completedNCT03715972
What this trial is testing

Cerebrovascular Reserve and White Matter Disease in Patients with Chronic Anemia

Who this might be right for
ThalassemiaSickle Cell DiseaseHealthy Controls
Children's Hospital Los Angeles 165
Testing effectiveness (Phase 2)Study completedNCT02435901
What this trial is testing

HSCT For Patients With High Risk Hemoglobinopathies Using Reduced Intensity

Who this might be right for
Sickle Cell DiseaseBeta Thalassemia-Major
Northwell Health 29
Post-approval studies (Phase 4)Enrolling By InvitationNCT05777993
What this trial is testing

Provide Access to Mitapivat for Participants Who Previously Participated in an Agios-Sponsored Mitapivat Study

Who this might be right for
Pyruvate Kinase DeficiencyAnemia, HemolyticSickle Cell Disease+1 more
Agios Pharmaceuticals, Inc. 59
Testing effectiveness (Phase 2)WithdrawnNCT01419704
What this trial is testing

Phase I/II Pilot Study of Mixed Chimerism to Treat Hemoglobinopathies

Who this might be right for
Anemia, Sickle CellComplex and Transfusion-dependent HemoglobinopathiesThalassemia+4 more
Talaris Therapeutics Inc.
Testing effectiveness (Phase 2)Active Not RecruitingNCT04053803
What this trial is testing

An Extension Study of IMR-687 in Adult Patients With Sickle Cell Anemia

Who this might be right for
Sickle Cell Disease
Imara, Inc. 30
Not applicableLooking for participantsNCT06250595
What this trial is testing

European Rare Blood Disorders Platform (ENROL)

Who this might be right for
AnemiaBone Marrow FailureBleeding Disorder+9 more
Hospital Universitari Vall d'Hebron Research Institute 37,090
Testing effectiveness (Phase 2)Study completedNCT03763656
What this trial is testing

Pharmacokinetics of Oral Hydroxyurea Solution

Who this might be right for
Sickle Cell DiseaseSickle-Cell; Hemoglobin Disease, ThalassemiaSickle Cell-beta-thalassemia+1 more
Nova Laboratories Limited 33
Testing effectiveness (Phase 2)Study completedNCT00125788
What this trial is testing

L-Glutamine Therapy for Sickle Cell Anemia and Sickle ß0 Thalassemia

Who this might be right for
Sickle Cell AnemiaThalassemia
Emmaus Medical, Inc. 70
Not applicableStudy completedNCT07305181
What this trial is testing

Prevalence of Abnormal Haemoglobin Variants in Metropolitan Chattogram, Bangladesh

Who this might be right for
HbE TraitHemoglobinopathies
Bangladesh Bioscience Research Group 8,400
Post-approval studies (Phase 4)Study completedNCT03176849
What this trial is testing

Phase IV Control Trial of Single High Dose Oral Vitamin D3 in Pediatric Patients Undergoing HSCT

Who this might be right for
Vitamin D DeficiencyStem Cell Transplant ComplicationsPediatric Cancer+7 more
Phoenix Children's Hospital 49
Not applicableEnded earlyNCT01534676
What this trial is testing

Effects of Transfusion of Older Stored Red Cells

Who this might be right for
Sickle Cell DiseaseThalassemia
Columbia University 3
Testing effectiveness (Phase 2)UnknownNCT02061800
What this trial is testing

CD34+ (Malignant) Stem Cell Selection for Patients Receiving Allogenic Stem Cell Transplant

Who this might be right for
Chronic Myeloid Leukemia (CML)Acute Myelogenous Leukemia (AML)Myelodysplastic Syndrome (MDS)+3 more
Diane George 14
Not applicableLooking for participantsNCT04528355
What this trial is testing

Data Collection Study of Patients With Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT With RIC

Who this might be right for
Primary Immunodeficiency (PID)Congenital Bone Marrow Failure SyndromesInherited Metabolic Disorders (IMD)+2 more
Paul Szabolcs 50
Next Page